CIK 0001570562 · Accelerated filer
Evolus, Inc.
Sign in to watch- Ticker
- EOLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461385614
- Phone
- (949) 284-4555
- Business address
- 520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
- Former names
- Evolus, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $950,019
- in 1 filing
Net −$950,019. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 29 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-24 | Parschauer Karah Herdman Director | Grant or award | +15,568 | 34,881 | ||
| 2022-01-24 | Parschauer Karah Herdman Director | Grant or award · Stock Option (Right to Buy) | +22,727 | 22,727 | ||
| 2022-01-24 | GILL DAVID N Director | Grant or award | +15,568 | 39,881 | ||
| 2022-01-24 | GILL DAVID N Director | Grant or award · Stock Option (Right to Buy) | +22,727 | 22,727 | ||
| 2022-01-24 | FARRELL PETER C Director | Grant or award | +15,568 | 34,881 | ||
| 2022-01-24 | FARRELL PETER C Director | Grant or award · Stock Option (Right to Buy) | +22,727 | 22,727 | ||
| 2022-01-24 | HAYMAN ROBERT Director | Grant or award | +15,568 | 34,881 | ||
| 2022-01-24 | HAYMAN ROBERT Director | Grant or award · Stock Option (Right to Buy) | +22,727 | 22,727 | ||
| 2022-01-24 | BLANK SIMONE Director | Grant or award | +15,568 | 34,881 | ||
| 2022-01-24 | BLANK SIMONE Director | Grant or award · Stock Option (Right to Buy) | +22,727 | 22,727 | ||
| 2022-01-05 | Stewart Brady Director | Grant or award | +36,508 | 36,508 | ||
| 2021-09-02 | Alphaeon 1 LLC 10% owner | Sale | −2,597,475 | $9.50 | $24.7M | 6,064,871 |
| 2021-08-27 | Medytox Inc. 10% owner | Purchase | +51,000 | $10.93 | $558K | 7,463,652 |
| 2021-08-26 | Medytox Inc. 10% owner | Purchase | +66,000 | $11.02 | $727K | 7,412,652 |
| 2021-08-25 | Medytox Inc. 10% owner | Purchase | +44,000 | $11.12 | $489K | 7,346,652 |
| 2021-08-24 | Medytox Inc. 10% owner | Purchase | +72,219 | $11.17 | $807K | 7,302,652 |
| 2021-08-23 | Malik Vikram Director | Sale | −26,077 | $11.00 | $287K | 1,143,701 |
| 2021-08-23 | Medytox Inc. 10% owner | Purchase | +69,781 | $11.03 | $770K | 7,230,433 |
| 2021-08-20 | Medytox Inc. 10% owner | Purchase | +48,000 | $10.56 | $507K | 7,160,652 |
| 2021-08-20 | Malik Vikram Director | Sale | −49,878 | $10.61 | $529K | 1,169,778 |
Page 11 of 16 · 303 trades